Skip to main content
. 2019 Apr 2;16(2):202–214. doi: 10.3988/jcn.2020.16.2.202

Table 2. Demographics and clinical characteristics of the aMCI and NC subgroups.

Variable Verbal-aMCI (n=12) Visual-aMCI (n=10) Both-aMCI (n=16) NC (n=37)
Age, years 71.0±11.42* 71.5±5.02* 68.6±6.78 64.6±11.7
Age at onset, years 70.2±10.19 68.2±5.18 65.7±7.16 64.4±11.41
Sex, female 8 (66.7) 8 (80.0) 11 (68.8) 20 (54.1)
Education, years 6.29±3.36* 8.80±5.15 8.34±5.01* 11.95±4.47
Disease duration, months 28.0±16.24 28.8±19.55 34.0±13.44 -
MMSE score 24.3±3.81* 26.1±2.13* 23.3±4.86* 28.4±1.76
CDR-SOB score 1.25±0.89* 0.80±0.58* 2.43±1.50* 0.00±0.00
APOE ε4 carrier 4 (33.3) 2 (20.0) 8 (50.0)* 8 (21.6)
Amyloid positivity 3/5 (60.0)* 2/3 (66.7)* 7/11 (63.6)* 0 (0)

Data are mean±SD values for continuous variables and n (%) values for categorical variables.

*p<0.05 versus NC in independent t-test for continuous variables and chi-square test for categorical variables.

aMCI: amnestic MCI, Both-aMCI: MCI with both visual and verbal memory impairment, CDR-SOB: Clinical Dementia Rating–Sum of Boxes, MCI: mild cognitive impairment, MMSE: Mini Mental State Examination, NC: normal cognition, Verbal-aMCI: MCI with verbal memory impairment, Visual-aMCI: MCI with visual memory impairment.